Avian Influenza Vaccines Market - Global Forecast 2026-2032

The avian influenza vaccines market is experiencing significant transformation as policy shifts, evolving disease threats, and supply chain considerations drive new priorities for industry stakeholders. Senior decision-makers are now navigating a landscape where vaccination strategies intersect with biosecurity, trade, and operational efficiency.

Market Snapshot: Avian Influenza Vaccines Market Overview

The Avian Influenza Vaccines Market grew from USD 778.02 million in 2025 to USD 851.38 million in 2026 and is projected to expand at a CAGR of 9.98%, reaching USD 1.51 billion by 2032. This sustained growth reflects mounting outbreak pressure, shifting regulatory expectations, and increasing demand for preventive animal health solutions in the poultry sector.

Scope & Segmentation

Vaccine Platforms: Inactivated, recombinant, and vector-based vaccines form the core platforms, each meeting different program objectives and operational needs.
Administration Methods: Includes injectable and mass-application routes, with feasibility influenced by labor, scale, and farm practices.
Species & Production Purpose: Products are used across layer, breeder, broiler, and turkey systems, tailored to differing bird values and production cycles.
End-User Segments: Commercial integrators, smaller producers, and public-sector vaccination programs, each with unique priorities around supply security, cost, and implementation.
Regions Covered: Americas, Europe, Middle East, Africa, and Asia-Pacific, with adoption patterns shaped by outbreak experience, policy stance, and trade exposure.
Companion Technologies: Diagnostics supporting DIVA compliance, post-vaccination surveillance tools, and supply solutions addressing cold-chain and rapid deployment challenges.

Key Takeaways for Decision-Makers

Vaccination is transitioning from contingency response to a core element of long-term disease management, driven by frequency and severity of recent outbreaks.
Strategic use of rapid platform technologies and regular strain updates is essential as virus evolution accelerates and operational continuity is prioritized.
DIVA-compatible vaccines and integrated monitoring are critical in enabling trade and policy compliance, especially in export-sensitive markets.
Adoption patterns diverge significantly across regions and farm segments due to varying surveillance capacity, production density, and supply logistics.
Manufacturers are investing in resilient supply chains, dual sourcing, and localized production to buffer against logistical and regulatory disruptions.
Public policy drives program adoption, with alignment between government and industry stakeholders greatly influencing the success and sustainability of vaccination efforts.

Tariff Impact: United States Market Dynamics

Upcoming United States tariff changes in 2025 introduce new complexities around input sourcing, contract terms, and vaccine supply resilience. Increased costs and customs delays related to imported vaccine components—from raw materials to packaging—necessitate a focus on total landed cost and agile supplier relationships. Organizations must revisit supply contracts, clarify tariff exposure, and bolster inventory management to mitigate disruption risks. Tariff-driven uncertainty also places a premium on domestic manufacturing capabilities, dual sourcing, and advanced contingency planning throughout the value chain.

Methodology & Data Sources

Research draws on structured primary interviews with key manufacturers, veterinary experts, and market stakeholders, complemented by rigorous review of policy documents, regulatory updates, and scientific literature. Cross-validation ensures that findings reflect consensus realities and actionable insights for commercial and policy leaders.

Why This Report Matters

Provides executive-level clarity on evolving technology platforms and regional shifts shaping the avian influenza vaccines market.
Equips decision-makers to anticipate supply chain vulnerabilities and policy developments affecting procurement, deployment, and program success.
Identifies actionable levers for operational readiness, from integrated surveillance to workforce training and risk management.

Conclusion

Successful avian influenza vaccine strategies depend on platform flexibility, integrated surveillance, and resilient supply networks. Industry leaders who embrace these priorities position themselves to maintain continuity and credibility amid evolving disease and policy landscapes.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Avian Influenza Vaccines Market, by Vaccine Type

8.1. Inactivated Vaccine
8.2. Live Attenuated Vaccine
8.3. Recombinant Vaccine
8.4. Subunit Vaccine

9. Avian Influenza Vaccines Market, by Animal Type

9.1. Broiler Chickens
9.2. Layer Hens
9.3. Waterfowl

10. Avian Influenza Vaccines Market, by Application

10.1. Preventive
10.1.1. Booster
10.1.2. Primary
10.2. Therapeutic

11. Avian Influenza Vaccines Market, by Administration Route

11.1. Drinking Water
11.2. Intramuscular
11.3. Spray
11.4. Subcutaneous

12. Avian Influenza Vaccines Market, by Virus Strain

12.1. H5N1
12.2. H7N9
12.3. H9N2

13. Avian Influenza Vaccines Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. Avian Influenza Vaccines Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Avian Influenza Vaccines Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States Avian Influenza Vaccines Market
17. China Avian Influenza Vaccines Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. AdvaCare Pharma Pte. Ltd.
18.6. AstraZeneca PLC
18.7. Bharat Biotech International Limited
18.8. BioNTech SE
18.9. Boehringer Ingelheim International GmbH
18.10. CAVAC S.A.
18.11. Ceva Santé Animale S.A.
18.12. Chengdu Tech-bank Biological Products Co., Ltd
18.13. CSL Limited
18.14. Daiichi Sankyo Company, Limited
18.15. Elanco Animal Health Incorporated
18.16. Emergent BioSolutions Inc.
18.17. Fatro S.P.A.
18.18. GlaxoSmithKline plc
18.19. Hester Biosciences Limited
18.20. HIPRA S.L.
18.21. Johnson & Johnson Private Limited
18.22. Medion S.A.
18.23. Merck & Co., Inc.
18.24. Mitsubishi Tanabe Pharma Corporation
18.25. Moderna, Inc.
18.26. Novavax, Inc.
18.27. Pfizer Inc.
18.28. Phibro Animal Health Corporation
18.29. QYH Biotech Company Limited
18.30. Sanofi S.A.
18.31. Seqirus UK Limited
18.32. Serum Institute of India Private Limited
18.33. Sinovac Biotech Ltd.
18.34. Vaxart, Inc.
18.35. Virbac S.A.
18.36. Zoetis Inc

List of Figures

FIGURE 1. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL AVIAN INFLUENZA VACCINES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL AVIAN INFLUENZA VACCINES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY VACCINE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY VIRUS STRAIN, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES AVIAN INFLUENZA VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA AVIAN INFLUENZA VACCINES MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY RECOMBINANT VACCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY RECOMBINANT VACCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY SUBUNIT VACCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY SUBUNIT VACCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY SUBUNIT VACCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY BROILER CHICKENS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY BROILER CHICKENS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY BROILER CHICKENS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY LAYER HENS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY LAYER HENS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY LAYER HENS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY WATERFOWL, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY WATERFOWL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY WATERFOWL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY PREVENTIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY PREVENTIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY PREVENTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY PREVENTIVE, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY BOOSTER, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY BOOSTER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY BOOSTER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY PRIMARY, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY PRIMARY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY PRIMARY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY DRINKING WATER, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY DRINKING WATER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY DRINKING WATER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY SPRAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY SPRAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY VIRUS STRAIN, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY H5N1, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY H5N1, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY H5N1, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY H7N9, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY H7N9, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY H7N9, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY H9N2, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY H9N2, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY H9N2, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. AMERICAS AVIAN INFLUENZA VACCINES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 64. AMERICAS AVIAN INFLUENZA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 65. AMERICAS AVIAN INFLUENZA VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 66. AMERICAS AVIAN INFLUENZA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 67. AMERICAS AVIAN INFLUENZA VACCINES MARKET SIZE, BY PREVENTIVE, 2018-2032 (USD MILLION)
TABLE 68. AMERICAS AVIAN INFLUENZA VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 69. AMERICAS AVIAN INFLUENZA VACCINES MARKET SIZE, BY VIRUS STRAIN, 2018-2032 (USD MILLION)
TABLE 70. NORTH AMERICA AVIAN INFLUENZA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. NORTH AMERICA AVIAN INFLUENZA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 72. NORTH AMERICA AVIAN INFLUENZA VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 73. NORTH AMERICA AVIAN INFLUENZA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 74. NORTH AMERICA AVIAN INFLUENZA VACCINES MARKET SIZE, BY PREVENTIVE, 2018-2032 (USD MILLION)
TABLE 75. NORTH AMERICA AVIAN INFLUENZA VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 76. NORTH AMERICA AVIAN INFLUENZA VACCINES MARKET SIZE, BY VIRUS STRAIN, 2018-2032 (USD MILLION)
TABLE 77. LATIN AMERICA AVIAN INFLUENZA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. LATIN AMERICA AVIAN INFLUENZA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 79. LATIN AMERICA AVIAN INFLUENZA VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 80. LATIN AMERICA AVIAN INFLUENZA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 81. LATIN AMERICA AVIAN INFLUENZA VACCINES MARKET SIZE, BY PREVENTIVE, 2018-2032 (USD MILLION)
TABLE 82. LATIN AMERICA AVIAN INFLUENZA VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 83. LATIN AMERICA AVIAN INFLUENZA VACCINES MARKET SIZE, BY VIRUS STRAIN, 2018-2032 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA AVIAN INFLUENZA VACCINES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA AVIAN INFLUENZA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA AVIAN INFLUENZA VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA AVIAN INFLUENZA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA AVIAN INFLUENZA VACCINES MARKET SIZE, BY PREVENTIVE, 2018-2032 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA AVIAN INFLUENZA VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA AVIAN INFLUENZA VACCINES MARKET SIZE, BY VIRUS STRAIN, 2018-2032 (USD MILLION)
TABLE 91. EUROPE AVIAN INFLUENZA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. EUROPE AVIAN INFLUENZA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 93. EUROPE AVIAN INFLUENZA VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 94. EUROPE AVIAN INFLUENZA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 95. EUROPE AVIAN INFLUENZA VACCINES MARKET SIZE, BY PREVENTIVE, 2018-2032 (USD MILLION)
TABLE 96. EUROPE AVIAN INFLUENZA VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 97. EUROPE AVIAN INFLUENZA VACCINES MARKET SIZE, BY VIRUS STRAIN, 2018-2032 (USD MILLION)
TABLE 98. MIDDLE EAST AVIAN INFLUENZA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. MIDDLE EAST AVIAN INFLUENZA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 100. MIDDLE EAST AVIAN INFLUENZA VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 101. MIDDLE EAST AVIAN INFLUENZA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 102. MIDDLE EAST AVIAN INFLUENZA VACCINES MARKET SIZE, BY PREVENTIVE, 2018-2032 (USD MILLION)
TABLE 103. MIDDLE EAST AVIAN INFLUENZA VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 104. MIDDLE EAST AVIAN INFLUENZA VACCINES MARKET SIZE, BY VIRUS STRAIN, 2018-2032 (USD MILLION)
TABLE 105. AFRICA AVIAN INFLUENZA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. AFRICA AVIAN INFLUENZA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 107. AFRICA AVIAN INFLUENZA VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 108. AFRICA AVIAN INFLUENZA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 109. AFRICA AVIAN INFLUENZA VACCINES MARKET SIZE, BY PREVENTIVE, 2018-2032 (USD MILLION)
TABLE 110. AFRICA AVIAN INFLUENZA VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 111. AFRICA AVIAN INFLUENZA VACCINES MARKET SIZE, BY VIRUS STRAIN, 2018-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC AVIAN INFLUENZA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC AVIAN INFLUENZA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC AVIAN INFLUENZA VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC AVIAN INFLUENZA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC AVIAN INFLUENZA VACCINES MARKET SIZE, BY PREVENTIVE, 2018-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC AVIAN INFLUENZA VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC AVIAN INFLUENZA VACCINES MARKET SIZE, BY VIRUS STRAIN, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. ASEAN AVIAN INFLUENZA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. ASEAN AVIAN INFLUENZA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 122. ASEAN AVIAN INFLUENZA VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 123. ASEAN AVIAN INFLUENZA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 124. ASEAN AVIAN INFLUENZA VACCINES MARKET SIZE, BY PREVENTIVE, 2018-2032 (USD MILLION)
TABLE 125. ASEAN AVIAN INFLUENZA VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 126. ASEAN AVIAN INFLUENZA VACCINES MARKET SIZE, BY VIRUS STRAIN, 2018-2032 (USD MILLION)
TABLE 127. GCC AVIAN INFLUENZA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GCC AVIAN INFLUENZA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 129. GCC AVIAN INFLUENZA VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 130. GCC AVIAN INFLUENZA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 131. GCC AVIAN INFLUENZA VACCINES MARKET SIZE, BY PREVENTIVE, 2018-2032 (USD MILLION)
TABLE 132. GCC AVIAN INFLUENZA VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 133. GCC AVIAN INFLUENZA VACCINES MARKET SIZE, BY VIRUS STRAIN, 2018-2032 (USD MILLION)
TABLE 134. EUROPEAN UNION AVIAN INFLUENZA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. EUROPEAN UNION AVIAN INFLUENZA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 136. EUROPEAN UNION AVIAN INFLUENZA VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 137. EUROPEAN UNION AVIAN INFLUENZA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 138. EUROPEAN UNION AVIAN INFLUENZA VACCINES MARKET SIZE, BY PREVENTIVE, 2018-2032 (USD MILLION)
TABLE 139. EUROPEAN UNION AVIAN INFLUENZA VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 140. EUROPEAN UNION AVIAN INFLUENZA VACCINES MARKET SIZE, BY VIRUS STRAIN, 2018-2032 (USD MILLION)
TABLE 141. BRICS AVIAN INFLUENZA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. BRICS AVIAN INFLUENZA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 143. BRICS AVIAN INFLUENZA VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 144. BRICS AVIAN INFLUENZA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 145. BRICS AVIAN INFLUENZA VACCINES MARKET SIZE, BY PREVENTIVE, 2018-2032 (USD MILLION)
TABLE 146. BRICS AVIAN INFLUENZA VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 147. BRICS AVIAN INFLUENZA VACCINES MARKET SIZE, BY VIRUS STRAIN, 2018-2032 (USD MILLION)
TABLE 148. G7 AVIAN INFLUENZA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. G7 AVIAN INFLUENZA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 150. G7 AVIAN INFLUENZA VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 151. G7 AVIAN INFLUENZA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 152. G7 AVIAN INFLUENZA VACCINES MARKET SIZE, BY PREVENTIVE, 2018-2032 (USD MILLION)
TABLE 153. G7 AVIAN INFLUENZA VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 154. G7 AVIAN INFLUENZA VACCINES MARKET SIZE, BY VIRUS STRAIN, 2018-2032 (USD MILLION)
TABLE 155. NATO AVIAN INFLUENZA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. NATO AVIAN INFLUENZA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 157. NATO AVIAN INFLUENZA VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 158. NATO AVIAN INFLUENZA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 159. NATO AVIAN INFLUENZA VACCINES MARKET SIZE, BY PREVENTIVE, 2018-2032 (USD MILLION)
TABLE 160. NATO AVIAN INFLUENZA VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 161. NATO AVIAN INFLUENZA VACCINES MARKET SIZE, BY VIRUS STRAIN, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL AVIAN INFLUENZA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. UNITED STATES AVIAN INFLUENZA VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 164. UNITED STATES AVIAN INFLUENZA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 165. UNITED STATES AVIAN INFLUENZA VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 166. UNITED STATES AVIAN INFLUENZA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 167. UNITED STATES AVIAN INFLUENZA VACCINES MARKET SIZE, BY PREVENTIVE, 2018-2032 (USD MILLION)
TABLE 168. UNITED STATES AVIAN INFLUENZA VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 169. UNITED STATES AVIAN INFLUENZA VACCINES MARKET SIZE, BY VIRUS STRAIN, 2018-2032 (USD MILLION)
TABLE 170. CHINA AVIAN INFLUENZA VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 171. CHINA AVIAN INFLUENZA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 172. CHINA AVIAN INFLUENZA VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 173. CHINA AVIAN INFLUENZA VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 174. CHINA AVIAN INFLUENZA VACCINES MARKET SIZE, BY PREVENTIVE, 2018-2032 (USD MILLION)
TABLE 175. CHINA AVIAN INFLUENZA VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 176. CHINA AVIAN INFLUENZA VACCINES MARKET SIZE, BY VIRUS STRAIN, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Avian Influenza Vaccines market report include:

AdvaCare Pharma Pte. Ltd.
AstraZeneca PLC
Bharat Biotech International Limited
BioNTech SE
Boehringer Ingelheim International GmbH
CAVAC S.A.
Ceva Santé Animale S.A.
Chengdu Tech-bank Biological Products Co., Ltd
CSL Limited
Daiichi Sankyo Company, Limited
Elanco Animal Health Incorporated
Emergent BioSolutions Inc.
Fatro S.P.A.
GlaxoSmithKline plc
Hester Biosciences Limited
HIPRA S.L.
Johnson & Johnson Private Limited
Medion S.A.
Merck & Co., Inc.
Mitsubishi Tanabe Pharma Corporation
Moderna, Inc.
Novavax, Inc.
Pfizer Inc.
Phibro Animal Health Corporation
QYH Biotech Company Limited
Sanofi S.A.
Seqirus UK Limited
Serum Institute of India Private Limited
Sinovac Biotech Ltd.
Vaxart, Inc.
Virbac S.A.
Zoetis Inc

Table Information

Report Attribute	Details
No. of Pages	198
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 851.38 Million
Forecasted Market Value ( USD ) by 2032	$ 1510 Million
Compound Annual Growth Rate	9.9%
Regions Covered	Global
No. of Companies Mentioned	33

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3505EUR$3,939USD£3,044GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3781EUR$4,249USD£3,283GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5125EUR$5,759USD£4,450GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6201EUR$6,969USD£5,385GBP

Market Snapshot: Avian Influenza Vaccines Market Overview

Scope & Segmentation

Key Takeaways for Decision-Makers

Tariff Impact: United States Market Dynamics

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Avian Influenza Vaccine Market - Global Strategic Business Report

2025 Global Forecast for Avian Influenza Vaccines Market (2026-2031 Outlook)-High Tech Outlook Report

Multivalent Influenza Vaccines Market - Global Forecast to 2030

Influenza Vaccine Market Size, Share, and Trends by Vaccine Type, Technology, Age Group, Route of Administration, Region, and Forecast 2025-2033

Influenza Vaccine Market: Analysis by Valency, Vaccine Type, Technology, Age Group, Route of Administration, Distribution Channel, and Region - Size, Trends and Forecasts to 2030